Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion type Assertion NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_head.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion wasGeneratedBy ECO_0000203 NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_provenance.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion wasDerivedFrom befree-20140225 NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_provenance.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion SIO_000772 21704278 NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_provenance.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion evidence source_evidence_literature NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_provenance.
- NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_assertion description "[Because we were interested in diagnostic and therapeutic consequences, we studied the KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary CRCs; in addition, we studied their available metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613880.RATiDSQ68Yw9EeqeC8MtzNctAToDplnNtfiNsgW3We6Ro130_provenance.